CF transmembrane conductance modulators CFTR
The new medications target the defective gene and permit the correct flow of salt and water to the lungs, thereby thinning the thick mucus that accumulates in the lungs. The Food and Drug Administration FDA has now approved these modulator brands, and they are prescribed to minors.
